Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology

BMC Cancer. 2018 Dec 4;18(1):1219. doi: 10.1186/s12885-018-5114-y.

Abstract

Background: Metastatic melanoma is one of the most aggressive forms of cancer in humans. Among its types, mucosal melanomas represent one of the most highly metastatic and aggressive forms, with a very poor prognosis. Because they are rare in Caucasian individuals, unlike cutaneous melanomas, there has been fewer epidemiological, clinical and genetic evaluation of mucosal melanomas. Moreover, the lack of predictive models fully reproducing the pathogenesis and molecular alterations of mucosal melanoma makes its treatment challenging. Interestingly, dogs are frequently affected by melanomas of the oral cavity that are characterized, as their human counterparts, by focal infiltration, recurrence, and metastasis to regional lymph nodes, lungs and other organs. In dogs, some particular breeds are at high risk, suggesting a specific genetic background and strong genetic drivers. Altogether, the striking homologies in clinical presentation, histopathological features, and overall biology between human and canine mucosal melanomas make dogs invaluable natural models with which to investigate tumor development, including tumor ætiology, and develop tailored treatments.

Methods: We developed and characterized two canine oral melanoma cell lines from tumors isolated from dog patients with distinct clinical profiles; with and without lung metastases. The cells were characterized using immunohistochemistry, pharmacology and genetic studies.

Results: We have developed and immunohistochemically, genetically, and pharmacologically characterized. Two cell lines (Ocr_OCMM1X & Ocr_OCMM2X) were produced through mouse xenografts originating from two clinically contrasting melanomas of the oral cavity. Their exhaustive characterization showed two distinct biological and genetic profiles that are potentially linked to the stage of malignancy at the time of diagnosis and sample collection of each melanoma case. These cell lines thus constitute relevant tools with which to perform genetic and drug screening analyses for a better understanding of mucosal melanomas in dogs and humans.

Conclusions: The aim of this study was to establish and characterize xenograft-derived canine melanoma cell lines with different morphologies, genetic features and pharmacological sensitivities that constitute good predictive models for comparative oncology. These cell lines are relevant tools to advance the use of canine mucosal melanomas as natural models for the benefit of both veterinary and human medicine.

Keywords: Cancer; Cell lines; Comparative oncology; Dog; Melanoma; Preclinical models.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Dogs
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Melanoma / diagnostic imaging*
  • Melanoma / drug therapy
  • Melanoma / genetics*
  • Melanoma, Cutaneous Malignant
  • Mice
  • Mice, Nude
  • Mouth Neoplasms / diagnostic imaging*
  • Mouth Neoplasms / drug therapy
  • Mouth Neoplasms / genetics*
  • Skin Neoplasms / diagnostic imaging*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / genetics*
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays / methods

Substances

  • Antineoplastic Agents